Citi cuts Hapvida profit estimates, sees no operational turnaround

Citi lowered its 2026 and 2027 profit projections for Brazilian healthcare operator Hapvida, citing a lack of operational turnaround despite recent share gains and expected rate cuts. The move signals persistent margin pressure and limited near-term earnings recovery, reinforcing a cautious stance on the stock.